<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05059535</url>
  </required_header>
  <id_info>
    <org_study_id>2021-A01321-40</org_study_id>
    <nct_id>NCT05059535</nct_id>
  </id_info>
  <brief_title>Knee Nerve Cryoneurolysis and Impact on Pain After Prosthetic Surgery</brief_title>
  <acronym>Cryogenou</acronym>
  <official_title>Cryoneurolysis of the Saphenous Nerve or Geniculate Nerves: Impact on Postoperative Pain and Rehabilitation in Prosthetic Knee Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GCS Ramsay Santé pour l'Enseignement et la Recherche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GCS Ramsay Santé pour l'Enseignement et la Recherche</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, comparative, randomized, controlled study versus standard treatment, in 3&#xD;
      parallel groups, monocentric, aiming to demonstrate the superiority of preoperative&#xD;
      cryoneurolysis versus no procedure, in patients operated on for knee arthroplasty and&#xD;
      receiving standard analgesia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>90 ° flexion pain 2 days after the arthroscopy</measure>
    <time_frame>2 days</time_frame>
    <description>Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>90 ° flexion pain 1 day after the arthroscopy</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90 ° flexion pain 7 days after the arthroscopy</measure>
    <time_frame>7 days</time_frame>
    <description>Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90 ° flexion pain 30 days after the arthroscopy</measure>
    <time_frame>30 days</time_frame>
    <description>Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90 ° flexion pain 90 days after the arthroscopy</measure>
    <time_frame>90 days</time_frame>
    <description>Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain at rest at Day 1</measure>
    <time_frame>1 day</time_frame>
    <description>Knee pain after intervention with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain at rest at Day 2</measure>
    <time_frame>2 days</time_frame>
    <description>Knee pain after intervention with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain at rest at Day 7</measure>
    <time_frame>7 days</time_frame>
    <description>Knee pain after intervention with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain at rest at Day 30</measure>
    <time_frame>30 days</time_frame>
    <description>Knee pain after intervention with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain at rest at Day 90</measure>
    <time_frame>90 days</time_frame>
    <description>Knee pain after intervention with a visual analogic scale of 100 mm</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Knee Injuries</condition>
  <arm_group>
    <arm_group_label>cryoneurolysis of the saphenous nerve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A cryoneurolysis of the saphenous nerve will be performed between 7 days and 5 days before the knee arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cryoneurolysis of geniculate nerves</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A cryoneurolysis of geniculate nerves will be performed between 7 days and 5 days before the knee arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No cryoneurolysis will be performed before the knee arthroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard pain relievers</intervention_name>
    <description>Knee arthroscopy will be performed ansd patients will receive standard pain relievers in confomtity with the current practice</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>cryoneurolysis of geniculate nerves</arm_group_label>
    <arm_group_label>cryoneurolysis of the saphenous nerve</arm_group_label>
    <other_name>Standard pain relievers in accordance with the current practice</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years and ≤ 80 years;&#xD;
&#xD;
          -  Patient to undergo prosthetic knee surgery;&#xD;
&#xD;
          -  Patient in good health (ASA score 1 to 3);&#xD;
&#xD;
          -  Patient able to understand the information related to the study, read the information&#xD;
             leaflet and agree to sign the consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known intolerance to any of the products administered during surgery or&#xD;
             cryoneurolysis;&#xD;
&#xD;
          -  Patient with an electric implant;&#xD;
&#xD;
          -  Patient with a contraindication to cryoanalgesia (coagulation disorders, infections,&#xD;
             nerve damage);&#xD;
&#xD;
          -  Drug addict patient;&#xD;
&#xD;
          -  Intervention on septic bone;&#xD;
&#xD;
          -  Chronic renal failure (creatinine clearance &lt;30 mL / min);&#xD;
&#xD;
          -  History of cryoglobulinemia, cold urticaria or Raynaud's syndrome;&#xD;
&#xD;
          -  Pregnant or breastfeeding woman;&#xD;
&#xD;
          -  Patient under guardianship or curatorship, or under a regime of deprivation of&#xD;
             liberty;&#xD;
&#xD;
          -  Patient participating in another clinical trial, or in a period of exclusion from&#xD;
             another clinical trial;&#xD;
&#xD;
          -  Patient not beneficiary of a social security scheme.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mourad MD AÏSSOU</last_name>
    <phone>+33625650434</phone>
    <email>aissou.mourad.sat@gmail.com</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 17, 2021</study_first_submitted>
  <study_first_submitted_qc>September 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

